---

	10/11/08	VGX Animal Health developing a DNA therapy for cancer
	10/7/08	VGX Animal Health announces the commercialization of its LifeTide™ SW 5 GHRH gene therapy product for pigs in Australia
	8/25/08	VGX Pharmaceuticals announces the publication of pivotal data from its LifeTide™ SW 5 studies, which led to the approval in Australia of the GHRH gene therapy product for pigs
	6/17/08	VGX Gene Therapy Technology Featured at the 90th Annual Endocrine Society Meeting
	5/22/08	VGX Pharmaceuticals announces publication in Molecular Therapy regarding the Company’s GHRH gene therapy product
	4/4/08	Preliminary Study Performed on New Laminitis Treatment Technique
	1/9/08	VGX Animal Health announces approval of LifeTide™ SW 5 - World’s First and Only Approved DNA Therapy for Food Animals
	11/7/07	VGX Animal Health Announces Promotion of Kevin W. Rassas to President
	5/07	The Scientist: Gene Therapy for Fido
	5/31/07	VGX Pharmaceuticals Announces Formation of Animal Health Company
	5/21/07	BusinessWeek: Development to Watch - VGX Pharmaceuticals
	2/26/07	VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division